[HTML][HTML] Clinical acceptance and dosimetric impact of automatically delineated elective target and organs at risk for head and neck MR-Linac patients

V Koteva, B Eiben, A Dunlop, A Gupta, T Gangil… - Frontiers in …, 2024 - frontiersin.org
Background MR-Linac allows for daily online treatment adaptation to the observed geometry
of tumor targets and organs at risk (OARs). Manual delineation for head and neck cancer …

Clinical acceptance and dosimetric impact of automatically delineated elective target and organs at risk for head and neck MR-Linac patients.

V Koteva, B Eiben, A Dunlop, A Gupta, T Gangil… - Frontiers in …, 2024 - europepmc.org
Background MR-Linac allows for daily online treatment adaptation to the observed geometry
of tumor targets and organs at risk (OARs). Manual delineation for head and neck cancer …

Clinical acceptance and dosimetric impact of automatically delineated elective target and organs at risk for head and neck MR-Linac patients

V Koteva, B Eiben, A Dunlop, A Gupta… - Frontiers in …, 2024 - pubmed.ncbi.nlm.nih.gov
Background MR-Linac allows for daily online treatment adaptation to the observed geometry
of tumor targets and organs at risk (OARs). Manual delineation for head and neck cancer …

[HTML][HTML] Clinical acceptance and dosimetric impact of automatically delineated elective target and organs at risk for head and neck MR-Linac patients

V Koteva, B Eiben, A Dunlop, A Gupta… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Background MR-Linac allows for daily online treatment adaptation to the observed geometry
of tumor targets and organs at risk (OARs). Manual delineation for head and neck cancer …

Clinical acceptance and dosimetric impact of automatically delineated elective target and organs at risk for head and neck MR-Linac patients.

V Koteva, B Eiben, A Dunlop, A Gupta, T Gangil… - Frontiers in …, 2024 - europepmc.org
Background MR-Linac allows for daily online treatment adaptation to the observed geometry
of tumor targets and organs at risk (OARs). Manual delineation for head and neck cancer …